The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease

AIM: To evaluate the clinical efficacy of the combined drug ascoril (Glenmark, India) in patients with grade I-II chronic obstructive pulmonary disease (COPD) concurrent with coronary heart disease (CHD)/MATERIAL AND METHODS: Sixty patients, including 12 (20%) women and 48 (80%) men, aged 43 to 68 y...

Full description

Bibliographic Details
Main Authors: N Iu Grigor'eva, A N Kuznetsov, T V Koroleva, M E Koroleva
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2013-08-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31349